| 000 | 01210 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512073003.0 | ||
| 264 | 0 | _c19870302 | |
| 008 | 198703s 0 0 eng d | ||
| 022 | _a0036-553X | ||
| 024 | 7 |
_a10.1111/j.1600-0609.1986.tb02632.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSheehan, T | |
| 245 | 0 | 0 |
_aThe efficacy and toxicity of VAD in the treatment of myeloma and related disorders. _h[electronic resource] |
| 260 |
_bScandinavian journal of haematology _cNov 1986 |
||
| 300 |
_a425-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aBacterial Infections _xchemically induced |
| 650 | 0 | 4 | _aDexamethasone |
| 650 | 0 | 4 |
_aDoxorubicin _xadverse effects |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoproliferative Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 |
_aVincristine _xadverse effects |
| 700 | 1 | _aJudge, M | |
| 700 | 1 | _aParker, A C | |
| 773 | 0 |
_tScandinavian journal of haematology _gvol. 37 _gno. 5 _gp. 425-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.1986.tb02632.x _zAvailable from publisher's website |
| 999 |
_c3815732 _d3815732 |
||